Federal Minister Senator Ahad Cheema has directed the Ministry of National Health Services and the Drug Regulatory Authority of Pakistan to urgently revise the country’s drug-pricing regulatory framework. The proposed reforms include changes to the Hardship Policy and the composition of the DRAP Policy Board. Cheema also called for the inclusion of a health economist and a public health expert on the board to strengthen evidence-based decisions and protect public interests.

Pakistan has approved prices for 52 new essential medicines covering cancer, hypertension, diabetes, respiratory diseases and infectious-disease vaccines. A drug-pricing committee chaired by Finance Minister Muhammad Aurangzeb approved the new molecules, which are expected to reach the market soon. According to industry reports, 87 essential medicines have received pricing approval during the past four months. The awaited notification may improve access to advanced treatments and enable pharmaceutical exports.

Artificial intelligence is rapidly transforming the healthcare industry, particularly in the fields of medical diagnostics and research. Advances in machine learning, data analysis, and computing power are enabling healthcare professionals to detect diseases earlier, analyze complex medical data more efficiently, and accelerate scientific discovery. In 2026, AI is becoming an increasingly valuable tool in hospitals, laboratories, and research institutions around the world. By assisting doctors and scientists in interpreting large volumes of medical information, AI technology is helping improve diagnostic accuracy and support faster medical decision-making, ultimately contributing to better patient outcomes.

One of the most significant applications of AI in healthcare is in medical imaging and diagnostics. AI-powered systems can analyze medical scans such as X-rays, CT scans, and MRI images with remarkable speed and precision. These systems are trained on large datasets of medical images and can identify patterns associated with various diseases, including cancers, cardiovascular conditions, and neurological disorders. In many cases, AI tools can highlight subtle abnormalities that may be difficult for the human eye to detect, helping radiologists and physicians make more accurate diagnoses. While AI does not replace medical professionals, it serves as a powerful support tool that enhances clinical decision-making.

AI is also revolutionizing medical research by accelerating the process of drug discovery and development. Traditionally, developing new medicines can take many years of testing and analysis. AI algorithms can now analyze biological data, chemical compounds, and clinical trial results to identify potential drug candidates more quickly. By simulating how different molecules interact with biological targets, AI can help researchers identify promising treatments and prioritize the most effective compounds for further study. This approach has the potential to reduce both the time and cost required to bring new medicines to market.

Another area where AI is making a significant impact is personalized medicine. By analyzing genetic information, lifestyle data, and medical history, AI systems can help doctors develop treatment plans tailored to individual patients. This personalized approach allows healthcare providers to select therapies that are more likely to be effective for specific patients while minimizing potential side effects. Advances in genomics and AI-driven data analysis are enabling researchers to better understand how different individuals respond to treatments, leading to more precise and targeted medical care.

AI is also improving the efficiency of clinical research and data management. Modern healthcare systems generate enormous amounts of data, including electronic medical records, laboratory results, and patient monitoring information. AI-powered tools can process and analyze this data to identify patterns that may reveal new insights into disease progression and treatment outcomes. Researchers can use these insights to design more effective clinical trials and develop improved healthcare strategies. By automating complex data analysis, AI allows scientists to focus more on innovation and less on time-consuming manual processes.

Despite its growing role in healthcare, experts emphasize that AI should complement rather than replace human expertise. Ethical considerations, data privacy, and regulatory oversight remain important factors in the responsible use of AI in medicine. Ensuring that AI systems are transparent, accurate, and free from bias is essential for maintaining trust in healthcare technology. As medical institutions continue to adopt AI tools, collaboration between technology developers, healthcare professionals, and policymakers will be necessary to ensure safe and effective integration.

Looking ahead, AI is expected to play an even larger role in shaping the future of diagnostics and medical research. Continued advancements in data science, biotechnology, and computing will likely lead to new breakthroughs in disease detection, treatment development, and patient care. As healthcare systems around the world embrace digital transformation, artificial intelligence is poised to become one of the most powerful tools driving innovation in modern medicine.